We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Contempo Updates |

Long QT Syndrome

Arthur J. Moss, MD
JAMA. 2003;289(16):2041-2044. doi:10.1001/jama.289.16.2041.
Text Size: A A A
Published online


The long QT syndrome (LQTS) was first described in 1957 in a family in which several children with congenital bilateral neural deafness and QT prolongation on electrocardiogram (ECG) experienced recurrent syncope and sudden death, with a family pattern that suggested autosomal recessive inheritance (Jervell and Lange-Nielsen syndrome).1 A similar and much more common familial disorder with QT prolongation but without deafness was described a few years later, with family patterns that suggested autosomal dominant inheritance (Romano-Ward syndrome). These reports highlighted the familial nature of this QT prolongation disorder, and subsequent studies identified malignant ventricular arrhythmias as the cause of syncope and sudden death in patients with LQTS. The molecular-genetic basis of LQTS was discovered in the 1990s and, currently, mutations have been identified in 7 LQTS genes (Table 1).

Figures in this Article


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Figure. Twelve-Lead Electrocardiogram From a Patient With the LQT3 Genotype of Long QT Syndrome
Graphic Jump Location
The electrocardiogram shows sinus bradycardia with a heart rate of 48/min, a QT interval of 0.68 seconds, and a corrected QT interval of 0.61 seconds. The long ST-segment interval before the onset of a late, prominent T wave is characteristic of the LQT3 genotype. The patient was not receiving β-blocker medication at the time this tracing was obtained.



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

132 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.